Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.12−0.13 (-1.79%)
Close on Nov 16, 2026Market cap $427.95MP/E –Yield –
Orchestra BioMed total assets
Total assets on the balance sheet at the end of each period.
Orchestra BioMed's total assets was $115.70M at Jun 30, 2026. For fiscal 2025 it was $114.86M, up 50.8% from the year before. The highest annual figure on record is $162.16M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.86M | +50.8% |
| FY2024 | Dec 31, 2024 | $76.17M | -20.0% |
| FY2023 | Dec 31, 2023 | $95.21M | -0.4% |
| FY2022 | Dec 31, 2022 | $95.57M | -40.9% |
| FY2021 | Dec 31, 2021 | $161.82M | -0.2% |
| FY2020 | Dec 31, 2020 | $162.16M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $115.70M | +170.2% |
| Q1 FY2026 | Mar 31, 2026 | $100.66M | +70.5% |
| Q4 FY2025 | Dec 31, 2025 | $114.86M | +50.8% |
| Q3 FY2025 | Sep 30, 2025 | $104.81M | +39.2% |
| Q2 FY2025 | Jun 30, 2025 | $42.83M | -40.8% |
| Q1 FY2025 | Mar 31, 2025 | $59.05M | -28.5% |
| Q4 FY2024 | Dec 31, 2024 | $76.17M | -20.0% |
| Q3 FY2024 | Sep 30, 2024 | $75.32M | -35.3% |
| Q2 FY2024 | Jun 30, 2024 | $72.38M | -42.5% |
| Q1 FY2024 | Mar 31, 2024 | $82.63M | -39.4% |
| Q4 FY2023 | Dec 31, 2023 | $95.21M | -0.4% |
| Q3 FY2023 | Sep 30, 2023 | $116.36M | +69.5% |
| Q2 FY2023 | Jun 30, 2023 | $125.88M | -22.1% |
| Q1 FY2023 | Mar 31, 2023 | $136.28M | -15.6% |
| Q4 FY2022 | Dec 31, 2022 | $95.57M | -40.9% |
| Q3 FY2022 | Sep 30, 2022 | $68.65M | -57.6% |
| Q2 FY2022 | Jun 30, 2022 | $161.58M | -0.3% |
| Q1 FY2022 | Mar 31, 2022 | $161.53M | -0.4% |
| Q4 FY2021 | Dec 31, 2021 | $161.82M | -0.2% |
| Q3 FY2021 | Sep 30, 2021 | $161.88M | -0.2% |
| Q2 FY2021 | Jun 30, 2021 | $162.03M | – |
| Q1 FY2021 | Mar 31, 2021 | $162.10M | – |
| Q4 FY2020 | Dec 31, 2020 | $162.16M | – |
| Q3 FY2020 | Sep 30, 2020 | $162.20M | – |
See a number that looks wrong?